Literature DB >> 7443734

Cumulative dose-response curves in behavioral pharmacology.

G R Wenger.   

Abstract

Cumulative dose-response curves have been widely used in many areas of pharmacology. To date, the applicability of cumulative dose-response curves has not been assessed in behavioral pharmacology. To determine the feasibility of this procedure, mice were trained to respond under a multiple time-out 5 min, fixed-ratio 30 (mult TO 5, FR 30) schedule of reinforcement. The FR 30 component consisted of 15 presentations of an FR 30 schedule of reinforcement. At the start of each TO 5 component, an intraperitoneal (IP) injection was given, and the effect on the response rate during the following 15 presentations of the FR 30 schedule was assessed. d-Amphetamine (0.3--30 mu moles/kg), pentobarbital (3-300 mu moles/kg), morphine (1-100 mu moles/kg), ketamine (3-300 mu moles/kg), and phencyclidine (1-100 mu moles/kg) all produced dose-related decreases in FR responding. In each case the lowest dose tested was without effect, and the highest dose tested essentially eliminated responding. As a control, the normal 4th dose in the ascending series of each drug was given preceded by 3 saline injections. Whether this dose of each drug was preceded by 3 separate saline injections or by 3 lower ascending doses of the same drug, the observed effect was identical. Five consecutive saline injections during the experimental session were without effect. The application of this procedure should greatly decrease the time required to examine the behavioral effects of a wide range of doses.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7443734     DOI: 10.1016/0091-3057(80)90007-6

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  23 in total

1.  Opioid modulation of the discriminative stimulus produced by pentylenetetrazol.

Authors:  M W Emmett-Oglesby; A Herz
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Effects of amphetamine-CNS depressant combinations and of other CNS stimulants in four-choice drug discriminations.

Authors:  Mi Li; William D Wessinger; D E McMillan
Journal:  J Exp Anal Behav       Date:  2005-07       Impact factor: 2.468

3.  Cross-tolerance and enhanced sensitivity to the response rate-decreasing effects of opioids with varying degrees of efficacy at the mu receptor.

Authors:  M J Picker; J Yarbrough
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  Tolerance to ethanol's disruptive effects on operant behavior in rats.

Authors:  F A Holloway; D A King; R C Michaelis; R D Harland; D C Bird
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  5-HT(1A) Receptor Null Mutant Mice Responding Under a Differential-Reinforcement-of-Low-Rate 72-Second Schedule of Reinforcement.

Authors:  Jonah J Scott-McKean; Galen R Wenger; Laurence H Tecott; Alberto C S Costa
Journal:  Open Neuropsychopharmacol J       Date:  2008-01-01

6.  Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals.

Authors:  Andrew S Huhn; Eric C Strain; George E Bigelow; Michael T Smith; Robert R Edwards; D Andrew Tompkins
Journal:  Anesthesiology       Date:  2019-01       Impact factor: 7.892

7.  Ultrasounds emitted by female rats during agonistic interactions: effects of morphine and naltrexone.

Authors:  M Haney; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1994-04       Impact factor: 4.530

8.  Rate dependency, behavioral mechanisms, and behavioral pharmacology.

Authors:  M N Branch
Journal:  J Exp Anal Behav       Date:  1984-11       Impact factor: 2.468

9.  Antihyperalgesic effects of imidazoline I(2) receptor ligands in rat models of inflammatory and neuropathic pain.

Authors:  Jun-Xu Li; David A Thorn; Yanyan Qiu; Bi-Wen Peng; Yanan Zhang
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

10.  Defeat engenders pentylenetetrazole-appropriate responding in rats: antagonism by midazolam.

Authors:  J A Vivian; E M Weerts; K A Miczek
Journal:  Psychopharmacology (Berl)       Date:  1994-12       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.